title: [Comment on the contribution by F. Zipp and K. P. Wandinger. Current recommendations for vaccinations in multiple sclerosis].
authors.forename: P
authors.initials: P
authors.lastname: Rieckmann
authors.forename: N
authors.initials: N
authors.lastname: Moriabadi
authors.forename: P
authors.initials: P
authors.lastname: Flachenecker
authors.forename: K
authors.initials: K
authors.lastname: Toyka
mesh_terms: D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007121:Immunocompetence / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D009103:Multiple Sclerosis / Q000276:immunology*; D012307:Risk Factors
chemical_list: D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines